Medium-chain triglycerides promote macrophage reverse cholesterol transport and improve atherosclerosis in ApoE-deficient mice fed a high-fat diet

Nutrition Research

Volumn 36, Issue 9, 2016, Pages 964-973

  Zhang, Xinsheng ^a   Zhang, Yong ^a   Liu, Yinghua ^a   Wang, Jin ^a   Xu, Qing ^a   Yu, Xiaoming ^a   Yang, Xueyan ^a   Liu, Zhao ^a   Xue, Changyong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

ApoE deficient mice; Atherosclerosis; Medium chain fatty acids; Medium chain triglycerides; Reverse cholesterol transport

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G5; ABC TRANSPORTER G8; APOLIPOPROTEIN E; BILE ACID; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; TRIACYLGLYCEROL; TRITIUM; ABC TRANSPORTER; CARRIER PROTEIN; MESSENGER RNA; NPC1L1 PROTEIN, MOUSE;

ABCA1 GENE; ABCG8 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTHROPOMETRIC PARAMETERS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BILE ACID BLOOD LEVEL; BODY FAT MASS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYP7A1 GENE; DOWN REGULATION; EPIDIDYMAL FAT WEIGHT; GENE; GENE EXPRESSION REGULATION; IN VIVO STUDY; ISOTOPE LABELING; LIPID ANALYSIS; LIPID DIET; LIVER WEIGHT; MACROPHAGE REVERSE CHOLESTEROL TRANSPORT; MALE; MOUSE; NONHUMAN; NPC1L1 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WILD TYPE; ADIPOSE TISSUE; ADMINISTRATION AND DOSAGE; ANIMAL; C57BL MOUSE; DEFICIENCY; DRUG EFFECTS; FAT INTAKE; GENETICS; INTESTINE; KNOCKOUT MOUSE; LIVER; MACROPHAGE; METABOLISM; PATHOLOGY; RAW 264.7 CELL LINE; TRANSPORT AT THE CELLULAR LEVEL;

ADIPOSE TISSUE; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; DIET, HIGH-FAT; DIETARY FATS; INTESTINES; LIVER; MACROPHAGES; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; RAW 264.7 CELLS; RNA, MESSENGER; TRIGLYCERIDES;

EID: 84981747759     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2016.06.004     Document Type: Article

References (39)

1. [1] Steinberg, D, Thematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia. J Lipid Res 46 (2005), 2037–2051, 10.1194/jlr.R500010-JLR200.
2. [2] Mensink, RP, Zock, PL, Kester, AD, Katan, MB, Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77 (2003), 1146–1155 [PubMed PMID: 12716665].
3. [3] Willett, WC, Dietary fats and coronary heart disease. J Intern Med 272 (2012), 13–24, 10.1111/j.1365–2796.2012.02553.x.
4. [4] Wijendran, V, Hayes, KC, Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr 24 (2004), 597–615, 10.1146/annurev.nutr.24.012003.132106.
5. [5] Yang, X, Zhang, Y, Lin, J, Pen, A, Ying, C, Cao, W, et al. A lower proportion of dietary saturated/monounsaturated/polyunsaturated fatty acids reduces the expression of adiponectin in rats fed a high-fat diet. Nutr Res 32 (2012), 285–291, 10.1016/j.nutres.2011.12.016.
6. [6] Kaunitz, H, Medium chain triglycerides (MCT) in aging and arteriosclerosis. J Environ Pathol Toxicol Oncol 6 (1986), 115–121 [PubMed PMID: 3519928].
7. [7] Decuypere, JA, Dierick, NA, The combined use of triacylglycerols containing medium-chain fatty acids and exogenous lipolytic enzymes as an alternative to in-feed antibiotics in piglets: concept, possibilities and limitations. An overview. Nutr Res Rev 16 (2003), 193–210, 10.1079/NRR200369.
8. [8] Bach, AC, Babayan, VK, Medium-chain triglycerides: an update. Am J Clin Nutr 36 (1982), 950–962 [PubMed PMID: 6814231].
9. [9] Nosaka, N, Maki, H, Suzuki, Y, Haruna, H, Ohara, A, Kasai, M, et al. Effects of margarine containing medium-chain triacylglycerols on body fat reduction in humans. J Atheroscler Thromb 10 (2003), 290–298, 10.5551/jat.10.290.
10. [10] Xue, C, Liu, Y, Wang, J, Zhang, R, Zhang, Y, Zhang, J, et al. Consumption of medium- and long-chain triacylglycerols decreases body fat and blood triglyceride in Chinese hypertriglyceridemic subjects. Eur J Clin Nutr 63 (2009), 879–886, 10.1038/ejcn.2008.76.
11. [11] Rego Costa, AC, Rosado, EL, Soares-Mota, M, Influence of the dietary intake of medium chain triglycerides on body composition, energy expenditure and satiety: a systematic review. Nutr Hosp 27 (2012), 103–108, 10.1590/S0212–16112012000100011.
12. [12] St-Onge, MP, Lamarche, B, Mauger, JF, Jones, PJ, Consumption of a functional oil rich in phytosterols and medium-chain triglyceride oil improves plasma lipid profiles in men. J Nutr 133 (2003), 1815–1820 [PubMed PMID: 12771322].
13. [13] Bourque, C, St-Onge, MP, Papamandjaris, AA, Cohn, JS, Jones, PJ, Consumption of an oil composed of medium chain triacyglycerols, phytosterols, and N-3 fatty acids improves cardiovascular risk profile in overweight women. Metabolism 52 (2003), 771–777, 10.1016/S0026–0495(03)00070–2.
14. [14] Cox, C, Sutherland, W, Mann, J, de Jong, S, Chisholm, A, Skeaff, M, Effects of dietary coconut oil, butter and safflower oil on plasma lipids, lipoproteins and lathosterol levels. Eur J Clin Nutr 52 (1998), 650–654 [PubMed PMID: 9756121].
15. [15] Liu, Y, Wang, J, Zhang, R, Zhang, Y, Xu, Q, Zhang, J, et al. A good response to oil with medium- and long-chain fatty acids in body fat and blood lipid profiles of male hypertriglyceridemic subjects. Asia Pac J Clin Nutr 18 (2009), 351–358 [PubMed PMID: 19786383].
16. [16] Liu, Y, Xue, C, Zhang, Y, Xu, Q, Yu, X, Zhang, X, et al. Triglyceride with medium-chain fatty acids increases the activity and expression of hormone-sensitive lipase in white adipose tissue of C57BL/6J mice. Biosci Biotechnol Biochem 75 (2011), 1939–1944, 10.1271/bbb.110321.
17. [17] Liu, Y, Zhang, Y, Xu, Q, Yu, X, Zhang, X, Wang, J, et al. Increased norepinephrine by medium-chain triglyceride attributable to lipolysis in white and brown adipose tissue of C57BL/6J mice. Biosci Biotechnol Biochem 76 (2012), 1213–1218, 10.1271/bbb.120079.
18. [18] Nishimoto, T, Pellizzon, MA, Aihara, M, Stylianou, IM, Billheimer, JT, Rothblat, G, et al. Fish oil promotes macrophage reverse cholesterol transport in mice. Arterioscler Thromb Vasc Biol 29 (2009), 1502–1508, 10.1161/ATVBAHA.109.187252.
19. [19] Kasbi Chadli, F, Nazih, H, Krempf, M, Nguyen, P, Ouguerram, K, Omega 3 fatty acids promote macrophage reverse cholesterol transport in hamster fed high fat diet. PLoS One, 8, 2013, e61109, 10.1371/journal.pone.0061109.
20. [20] Xu, Q, Xue, C, Zhang, Y, Liu, Y, Wang, J, Yu, X, et al. Medium-chain fatty acids enhanced the excretion of fecal cholesterol and cholic acid in C57BL/6J mice fed a cholesterol-rich diet. Biosci Biotechnol Biochem 77 (2013), 1390–1396, 10.1271/bbb.120999.
21. [21] Farina, AC, Hirabara, S, Sain, J, Latorre, ME, Gonzalez, M, Curi, R, et al. Conjugated linoleic acid improves glucose utilization in the soleus muscle of rats fed linoleic acid-enriched and linoleic acid-deprived diets. Nutr Res 34 (2014), 1092–1100, 10.1016/j.nutres.2014.09.008.
22. [22] Zhang, J, Kris-Etherton, PM, Thompson, JT, Hannon, DB, Gillies, PJ, Heuvel, JP, Alpha-linolenic acid increases cholesterol efflux in macrophage-derived foam cells by decreasing stearoyl CoA desaturase 1 expression: evidence for a farnesoid-X-receptor mechanism of action. J Nutr Biochem 23 (2012), 400–409, 10.1016/j.jnutbio.2011.01.004.
23. [23] Zhang, J, Cai, S, Peterson, BR, Kris-Etherton, PM, Heuvel, JP, Development of a cell-based, high-throughput screening assay for cholesterol efflux using a fluorescent mimic of cholesterol. Assay Drug Dev Technol 9 (2011), 136–146, 10.1089/adt.2010.0288.
24. [24] Zhang, J, Grieger, JA, Kris-Etherton, PM, Thompson, JT, Gillies, PJ, Fleming, JA, et al. Walnut oil increases cholesterol efflux through inhibition of stearoyl CoA desaturase 1 in THP-1 macrophage-derived foam cells. Nutr Metab, 8, 2011, 61, 10.1186/1743–7075–8-61.
25. [25] Nomura, J, Busso, N, Ives, A, Matsui, C, Tsujimoto, S, Shirakura, T, et al. Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice. Sci Rep, 4, 2014, 4554, 10.1038/srep04554.
26. [26] Heo, KN, Lin, X, Han, IK, Odle, J, Medium-chain fatty acids but not L-carnitine accelerate the kinetics of [14C]triacylglycerol utilization by colostrum-deprived newborn pigs. J Nutr 132 (2002), 1989–1994 [PubMed PMID: 12097681].
27. [27] Nagata, J, Kasai, M, Negishi, S, Saito, M, Effects of structured lipids containing eicosapentaenoic or docosahexaenoic acid and caprylic acid on serum and liver lipid profiles in rats. Biofactors 22 (2004), 157–160, 10.1002/biof.5520220131.
28. [28] St-Onge, MP, Bosarge, A, Goree, LL, Darnell, B, Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil. J Am Coll Nutr 27 (2008), 547–552, 10.1080/07315724.2008.10719737.
29. [29] Zhang, Y, Liu, Y, Wang, J, Zhang, R, Jing, H, Yu, X, et al. Medium- and long-chain triacylglycerols reduce body fat and blood triacylglycerols in hypertriacylglycerolemic, overweight but not obese, Chinese individuals. Lipids 45 (2010), 501–510, 10.1007/s11745–010-3418-z.
30. [30] Nagao, K, Yanagita, T, Medium-chain fatty acids: functional lipids for the prevention and treatment of the metabolic syndrome. Pharmacol Res 61 (2010), 208–212, 10.1016/j.phrs.2009.11.007.
31. [31] Tsuji, H, Kasai, M, Takeuchi, H, Nakamura, M, Okazaki, M, Kondo, K, Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. J Nutr 131 (2001), 2853–2859 [PubMed PMID: 11694608].
32. [32] De Oliveira Otto, MC, Wu, JH, Baylin, A, Vaidya, D, Rich, SS, Tsai, MY, et al. Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the multi-ethnic study of atherosclerosis. J Am Heart Assoc, 2, 2013, e000506, 10.1161/JAHA.113.000506.
33. [33] Dasgupta, S, Bhattacharyya, DK, Dietary effect of capric acid containing soyphospholipids. J Oleo Sci 58 (2009), 395–401, 10.5650/jos.58.395.
34. [34] Arbones-Mainar, JM, Navarro, MA, Acin, S, Guzman, MA, Arnal, C, Surra, JC, et al. Trans-10, cis-12- and cis-9, trans-11-conjugated linoleic acid isomers selectively modify HDL-apolipoprotein composition in apolipoprotein E knockout mice. J Nutr 136 (2006), 353–359 [PubMed PMID: 16424111].
35. [35] Zhang, L, Geng, Y, Xiao, N, Yin, M, Mao, L, Ren, G, et al. High dietary n-6/n-3 PUFA ratio promotes HDL cholesterol level, but does not suppress atherogenesis in apolipoprotein E-null mice 1. J Atheroscler Thromb 16 (2009), 463–471, 10.5551/jat.No1347.
36. [36] Lee, J, Park, Y, Koo, SI, ATP-binding cassette transporter A1 and HDL metabolism: effects of fatty acids. J Nutr Biochem 23 (2012), 1–7, 10.1016/j.jnutbio.2011.03.001.
37. [37] Rubin, D, Helwig, U, Pfeuffer, M, Auinger, A, Ruether, A, Matusch, D, et al. The effect of FABP2 promoter haplotype on response to a diet with medium-chain triacylglycerols. Genes Nutr 7 (2012), 437–445, 10.1007/s12263–012-0280-z.
38. [38] Xie, P, Jia, L, Ma, Y, Ou, J, Miao, H, Wang, N, et al. Ezetimibe inhibits hepatic Niemann-pick C1-like 1 to facilitate macrophage reverse cholesterol transport in mice. Arterioscler Thromb Vasc Biol 33 (2013), 920–925, 10.1161/ATVBAHA.112.301187.
39. [39] Dikkers, A, Freak de Boer, J, Annema, W, Groen, AK, Tietge, UJ, Scavenger receptor BI and ABCG5/G8 differentially impact biliary sterol secretion and reverse cholesterol transport in mice. Hepatology 58 (2013), 293–303, 10.1002/hep.26316.